
Moderna
OrganizationOn 2 shows in Health & Science this week · 1.6× usual · most on BioCentury This Week
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It develops RNA therapeutics, especially mRNA vaccines, using messenger RNA to instruct cells to produce proteins that can generate immune responses; its pipeline also includes programs targeting infectious diseases and cancer.
Rank this week
Share of the conversation
1.1‰ of what listeners heard
Reach this week
Tone this week
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Moderna per 1,000 mentions of anything, 7-day rolling, health & science.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 3 | 0.23‰ | 1 |
| Oct 4 | 0.23‰ | 1 |
| Oct 8 | 0.45‰ | 1 |
| Oct 10 | 0.65‰ | 1 |
| Oct 12 | 0.68‰ | 1 |
| Oct 13 | 0.91‰ | 1 |
| Oct 16 | 1.38‰ | 3 |
| Oct 17 | 1.41‰ | 1 |
| Oct 23 | 1.29‰ | 5 |
| Oct 27 | 1.81‰ | 3 |
| Oct 30 | 1.72‰ | 4 |
| Nov 16 | 0.35‰ | 2 |
| Nov 17 | 0.67‰ | 2 |
Why is it trending?· Last 7 days
Moderna’s melanoma vaccine data prompts debate over cancer-vaccine prospects
Moderna and Merck released anticipated results for a personalized mRNA vaccine in resected melanoma, with the study described as positive and its primary endpoint achieved.[1][2][3]
On BioCentury This Week, Lauren Martz said melanoma is both a useful test of immunotherapy and a difficult setting because other immunotherapies have worked there.[4]
On Breaking Biotech, Matthew Cloutier discussed the full Intrapath 001 results and said Moderna’s sell-off would probably continue.[5]
The Readout Loud questioned whether the results were the conference’s most impactful, while Biotech Hangout contrasted Moderna’s platform with a different vaccine approach and raised questions about lipid nanoparticles.[3][6]
Sources · 6 moments
- 1.BioCentury This Week · Ep. 394 - Security concerns in U.S., China reshaping biotechJeff Cranmer · Oct 27 · Listen at 0:52 ↗
“with a $1 .3 billion deal with Gilead. What is the tech that attracted the Bay Area big biotech? And last week, much anticipated data from Merck and Moderna on their melanoma vaccine bring the adoption test into focus. Joining me to discuss”
- 2.Breaking Biotech · 120 - Breaking Biotech Week End Wrap Up - Oct 25th, 2026Matthew Cloutier · Oct 26 · Listen at 6:05 ↗
“matter because there might just be enough people willing to pump this thing up as much as it is like a huge, pretty, pretty large market cap right now. There's a lot going on there. What ended up happening is at ESMO, Moderna was scheduled”
- 3.The Readout Loud · 419: Assessing Merck and Moderna's mRNA cancer vaccineAllison DeAngelis · Oct 30 · Listen at 1:53 ↗
“Well, okay. Before you go back to your Mai Tais or whatever you're enjoying, tell us about ESMO. I want to start off with the juiciest, most eye-catching news of the week, which were these results from Moderna and Merck's cancer vaccine. Wh”
- 4.BioCentury This Week · Ep. 394 - Security concerns in U.S., China reshaping biotechLauren Martz · Oct 27 · Listen at 27:48 ↗
“Well, so first I would say we don't know how large that effect size has to be. That's still an unknown at this point. But I think this could go either way. So Moderna and Merck went into melanoma as their first indication, which can be a go”
Written by AI from the cited moments; every quote is checked against the transcript.
Who is saying what about Moderna
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Matthew Cloutier16 claims on 1 show
“Moderna's technology is uniquely suited for this”
Breaking Biotech · Nov 9 ↗ - Jim Cramer9 claims on 1 show
“Moderna was a $63 stock. The next day, it closed above $174”
Mad Money w/ Jim Cramer · Nov 13 ↗ - John Coogan5 claims on 1 show
“the phase three did succeed, but the results weren't as spectacular as investors had hoped.”
TBPN · Oct 23 ↗
27 more with Pro.
Discussed alongside
Names that come up in the same conversations as Moderna.
Embed this
Paste this on your site to show Moderna's current trend:
<iframe src="https://podlume.ai/embed/e/moderna" width="360" height="220" style="border:0" loading="lazy" title="Moderna on PodLume Trends"></iframe>